Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NFAT (Nuclear Factor of Activated T-cells)-Regulated Gene Expression After Tacrolimus -the Basis for Future Tailored Immunosuppression-

NCT03315858 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT03315858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03315858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NFAT (Nuclear Factor of Activated T-cells)-Regulated Gene Expression After Tacrolimus -the Basis for Future Tailored Immunosuppression-
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Completed
Start date
January 18, 2019
Completion date
November 29, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nfat regulated gene expression in tacrolimus treated patients